|
补肾益精法治疗肾精不足型肾性骨病的临床观察
|
Abstract:
肾性骨病是慢性肾脏病(chronic kidney disease, CKD)的常见并发症,发病概率会随着慢性肾脏病的进展而增加发病几率,发展到慢性肾脏病终末期尿毒症时发病概率近乎100%。近年来血液净化透析技术越来越成熟,使得患者生存期延长,慢性肾脏病患者合并肾性骨病的可能性越来越高,值得临床医护及患者共同提高关注度,早一步发现就能早一步控制,能尽可能及时和有效地控制病情进展。
Renal bone disease is a common complication of chronic kidney disease (CKD), and the incidence rate will increase with the progression of CKD, and the incidence rate will be nearly 100% when it develops to end-stage uremia of CKD. In recent years, the technology of blood purification and dialysis has become more and more mature, prolonging the survival of patients, and increasing the possibility of chronic kidney disease patients with renal bone disease, which is worthy of clinical care and patients to pay more attention to, early detection can be controlled as early as possible, and the progress of the disease can be controlled as timely and effectively as possible.
[1] | 王莉, 李贵森, 刘志红. 中华医学会肾脏病学分会《慢性肾脏病矿物质和骨异常诊治指导》[J]. 肾脏病与透析肾移植杂志, 2013, 22(6): 554-559. |
[2] | 董柏涵. 补肾壮骨方治疗肾精不足型肾性骨病的临床观察[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2018. |
[3] | 上海慢性肾脏病早发现及规范化诊治与示范项目专家组, 高翔, 梅长林. 慢性肾脏病筛查诊断及防治指南[J]. 中国实用内科杂志, 2017, 37(1): 28-34. |
[4] | 黎磊石, 刘志红. 中国肾脏病学[M]. 北京: 人民军医出版社, 2008: 1309-1327. |
[5] | 郑莜萸. 中药新药临床研究指导原则(试行) [M]. 北京: 中国医药科技出版社, 2002: 163-168. |